In China's vitamin market, prices for most categories remain stable, with downstream purchases primarily driven by essential demand. Inquiry and trading activity continue to be light.
On October 29th, 2024, Star Lake Bioscience Co., Inc. Zhaoqing Guangdong released its Q3 2024 Financial Report, indicating its operation revenue of 4,303 million yuan for Q3 2024
On October 28th, 2024, Anhui Huaheng Biotechnology Co., Ltd. released its Q3 2024 Financial Report, revealing that the operation revenue for Q3 2024 reached 523 million yuan, a year-over-year increase
On October 27th, Xiamen Kingdomway Group Company announced its financial results for the first three quarters of 2024, reporting operation revenue of RMB 2.343 billion, a slight increase of 0.95% year
On October 26th, North China Pharmaceutical Co., Ltd. announced approximately RMB 7.56 billion in operation revenue during the first three quarters of 2024, recording a 5.2% year-on-year fall. Net pro
On October 25th, 2024, Zhejiang Hengtong Holding Co., Ltd. released its Q3 2024 financial report, showing operation revenue of RMB 347 million for the report period, a year-on-year soar of 119.45%. Ne
On October 25th, Zhejiang Shengda Bio-Pharm Co., Ltd. released its Q3 2024 financial report, showing operation revenue of RMB 609 million for the first three quarters of this year, a year-on-year incr
On October 27th, Hubei Nenter & Co., Inc. released its Q3 2024 financial report, showing operation revenue of RMB 9.288 billion for the first three quarters of this year, a 17.00% year-on-year increas